TARS - Tarsus Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TARS is currently covered by 5 analysts with an average price target of $65.77. This is a potential upside of $19.19 (41.2%) from yesterday's end of day stock price of $46.58.

Tarsus Pharmaceuticals 's activity chart (see below) currently has 7 price targets and 26 ratings on display. The stock rating distribution of TARS is 85% BUY and 15% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.52% with an average time for these price targets to be met of 327.88 days.

Highest price target for TARS is $65, Lowest price target is $41, average price target is $65.77.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 15-Nov-2024. First documented stock forecast 22-Jun-2021.

Currently out of the existing stock ratings of TARS, 17 are a BUY (85%), 3 are a HOLD (15%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$41

$-3 (-6.82%)

$30

6 days ago
(15-Nov-2024)

2/3 (66.67%)

$-3 (-6.82%)

19

Buy

$65

$21 (47.73%)

$63

7 days ago
(14-Nov-2024)

2/7 (28.57%)

$15.1 (30.26%)

630

Buy

$61

$17 (38.64%)

$57

6 months 8 days ago
(13-May-2024)

5/9 (55.56%)

$22.63 (58.98%)

697

Buy

$60

$16 (36.36%)

$50

6 months 11 days ago
(10-May-2024)

1/3 (33.33%)

$23 (62.16%)

820

Buy

$49

$5 (11.36%)

$46

1 years 2 months 10 days ago
(11-Sep-2023)

3/3 (100%)

$32.02 (188.57%)

457

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?

On average it took 327.88 days on average for the stock forecasts to be realized with a an average price target met ratio 35.52

Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

EDDIE HICKMAN

Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

BALAJI PRASAD

Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?

Eddie Hickman works at GUGGENHEIM and has 5 price targets and 3 ratings on TARS

Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?

Dane Leone with highest potential upside - $51.89

Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?

Andrea Tan with lowest potential downside - -$3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?